Compare NCPL & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCPL | HKPD |
|---|---|---|
| Founded | 1984 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Investment Managers | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 10.6M |
| IPO Year | N/A | 2025 |
| Metric | NCPL | HKPD |
|---|---|---|
| Price | $0.92 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 372.3K | 135.0K |
| Earning Date | 12-12-2025 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $917,291.00 | ★ $20,313,818.00 |
| Revenue This Year | $739.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.63 | $0.75 |
| 52 Week High | $8.75 | $3.79 |
| Indicator | NCPL | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 32.89 | 29.39 |
| Support Level | $0.81 | $0.75 |
| Resistance Level | $1.26 | $1.11 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 22.22 | 7.97 |
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.